TAIANA, ELISA
TAIANA, ELISA
Dipartimento di Oncologia ed Emato-Oncologia
Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?
2021-01-07 P. Menichini, P. Monti, A. Speciale, G. Cutrona, S. Matis, F. Fais, E. Taiana, A. Neri, R. Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza
The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracil
2015-01-01 M.B. Gariboldi, E. Taiana, M.C. Bonzi, I. Craparotta, S. Giovannardi, M. Mancini, E. Monti
Bioinformatics Pipeline to Analyze lncRNA Arrays
2021-01-01 K. Todoerti, D. Ronchetti, M. Manzoni, E. Taiana, A. Neri, L. Agnelli
Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells
2014-01-01 M. Mancini, M.B. Gariboldi, E. Taiana, M.C. Bonzi, I. Craparotta, M. Pagin, E. Monti
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma
2018-04-26 D. Ronchetti, L. Agnelli, A. Pietrelli, K. Todoerti, M. Manzoni, E. Taiana, A. Neri
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network
2021-01-01 E. Morelli, A. Gulla', N. Amodio, E. Taiana, A. Neri, M. Fulciniti, N.C. Munshi
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome
2021-10-01 K. Todoerti, D. Ronchetti, V. Favasuli, F. Maura, F. Morabito, N. Bolli, E. Taiana, A. Neri
Disentangling the microRNA regulatory milieu in multiple myeloma : integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients
2016-01-01 E. Calura, A. Bisognin, M. Manzoni, K. Todoerti, E. Taiana, G. Sales, G.J. Morgan, G. Tonon, N. Amodio, P. Tassone, A. Neri, L. Agnelli, C. Romualdi, S. Bortoluzzi
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma
2021-01-01 K. Todoerti, D. Ronchetti, N. Puccio, I. Silvestris, V. Favasuli, N. Amodio, M. Gentile, F. Morabito, A. Neri, E. Taiana
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma
2016-03-22 D. Ronchetti, L. Agnelli, E. Taiana, S. Galletti, M. Manzoni, K. Todoerti, P. Musto, F. Strozzi, A. Neri
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity
2018-02-22 N. Amodio, M.A. Stamato, G. Juli, E. Morelli, M. Fulciniti, M. Manzoni, E. Taiana, L. Agnelli, M.E.G. Cantafio, E. Romeo, L. Raimondi, D. Caracciolo, V. Zuccalà, M. Rossi, A. Neri, N.C. Munshi, P. Tagliaferri, P. Tassone
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs
2021-03-21 P. D'Aquila, D. Ronchetti, M.E. Gallo Cantafio, K. Todoerti, E. Taiana, F. Fabiani, A. Montesanto, A. Neri, G. Passarino, G. Viglietto, D. Bellizzi, N. Amodio
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing
2019-02-19 L. Agnelli, A. Bisognin, K. Todoerti, M. Manzoni, E. Taiana, S. Galletti, G. Cutrona, E. Gaffo, S. Bortoluzzi, A. Neri
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma
2020-03-25 D. Ronchetti, K. Todoerti, C. Vinci, V. Favasuli, L. Agnelli, M. Manzoni, F. Pelizzoni, R. Chiaramonte, N. Platonova, N. Giuliani, P. Tassone, N. Amodio, A. Neri, E. Taiana
Frequency and clinical relevance of coding and noncoding NOTCH1 mutations in early stage Binet A chronic lymphocytic leukemia patients
2020-01-01 M. Lionetti, M. Barbieri, V. Favasuli, E. Taiana, S. Fabris, C. Favoino, G. Ciceri, S. Matis, M. Colombo, R. Massara, G. Reda, M. Gentile, V. Spina, D. Rossi, L. Baldini, G. Gaidano, F. Fais, M. Ferrarini, F. Morabito, G. Cutrona, A. Neri
Genomic instability in multiple myeloma: A “non‐coding rna” perspective
2021-05-01 E. Taiana, M.E.G. Cantafio, V.K. Favasuli, C. Bandini, G. Viglietto, R. Piva, A. Neri, N. Amodio
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
2020-10-28 P. Monti, P. Menichini, A. Speciale, G. Cutrona, F. Fais, E. Taiana, A. Neri, R. Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza
In Vitro Silencing of lncRNAs Using LNA GapmeRs
2021-01-01 E. Taiana, V. Favasuli, D. Ronchetti, E. Morelli, P. Tassone, G. Viglietto, N.C. Munshi, A. Neri, N. Amodio
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways
2017-02-28 S. Manni, M. Carrino, M. Manzoni, K. Gianesin, S.C. Nunes, M. Costacurta, L.Q. Tubi, P. Macaccaro, E. Taiana, A. Cabrelle, G. Barilà, A. Martines, R. Zambello, L. Bonaldi, L. Trentin, A. Neri, G. Semenzato, F. Piazza
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells
2020-09-11 M.T. Palano, D. Giannandrea, N. Platonova, G. Gaudenzi, M. Falleni, D. Tosi, E. Lesma, V. Citro, M. Colombo, I. Saltarella, R. Ria, N. Amodio, E. Taiana, A. Neri, G. Vitale, R. Chiaramonte